Arch Capital vs Everest
ACGLN and EG side by side, both in fire, marine, and casualty insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACGLN and EG compare
Everest is the larger company, worth 3.0 times as much as Arch Capital ($15.8B against $5.2B).
On earnings, Arch Capital is cheaper: it trades at 1.2× trailing earnings, against 8.7× for Everest.
Arch Capital grew revenue faster over the last twelve months (−3.9% versus −8.7% for Everest).
Arch Capital keeps more of each dollar of sales as profit, with a net margin of 23.3% compared with 11.7% at Everest.
Both pay dividends: Arch Capital yields 7.5% and Everest 1.5%.
Arch Capital scores higher on the StockData Score (16 against 13 for Everest), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACGLN | EG |
|---|---|---|
| Size and price | ||
| Market cap | $5.2B | $15.8B |
| Share price | $15.15 | $411.11 |
| Change, 1 year | −13.8% | 27.7% |
| Change, 5 years | −41.1% | 50.0% |
| Beta (5Y) | 0.32 | 0.39 |
| Employees | 8,000 | 3,064 |
| StockData Score | ||
| Total score | 16 (better) | 13 |
| Valuation score | 6 | 6 |
| Growth score | 2 | 2 |
| Performance score | 5 (better) | 2 |
| Health score | 0 | 0 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 1.2× (better) | 8.7× |
| P/S | 0.3× (better) | 1.0× |
| P/B | 0.2× (better) | 1.1× |
| P/FCF | 0.9× | – |
| PEG | 0.03 (better) | 0.24 |
| FCF yield | 109% | – |
| Fair value | $70.98 | $578.67 |
| Margin of safety | 78.7% (better) | 29.0% |
| Growth | ||
| Revenue growth (TTM) | −3.9% (better) | −8.7% |
| Revenue growth, 5Y average | 18.6% (better) | 12.8% |
| Net income growth (TTM) | 6.9% | 243% (better) |
| EPS growth (TTM) | 14.5% | 256% (better) |
| EPS growth, 5Y average | 28.4% (better) | 24.2% |
| Profitability | ||
| Net margin | 23.3% (better) | 11.7% |
| FCF margin | 30.0% | – |
| Return on equity | 18.7% (better) | 12.8% |
| Financial health | ||
| Altman Z-score | 0.78 | 0.86 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 7.5% (better) | 1.5% |
| Payout ratio | – | 16.7% |
| Years of dividend growth | 0 | 4 (better) |
| Dividend growth, 5Y average | – | 5.2% |
| Buyback yield | 80.9% (better) | 10.1% |
| Shareholder yield | 88.4% (better) | 11.6% |
| Ownership | ||
| Held by institutions | 91.6% | 102% |
| Held by insiders | 5.5% | 1.6% |
| Insider net buying, 12 months | −$28.0M | −$333K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 4.5% |
Go deeper
- ACGLN stock overview
- ACGLN income statement
- ACGLN valuation and score
- EG stock overview
- EG income statement
- EG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.